FDA Inspection 1250227 - Raritan Pharmaceuticals, Inc. - April 02, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Raritan Pharmaceuticals, Inc., with an inspection on April 2, 2025, issued by the New Jersey District Office, covering human drugs.

Company: Raritan Pharmaceuticals, Inc.
Inspection Date: April 2, 2025
Product Type: Human Drugs
Office: New Jersey District Office

Open in Dashboard

ID · 1a844f99-5473-4890-a8bf-2c8de0080187

Violation Codes6

21 CFR 211.100(a)21 CFR 211.160(b)21 CFR 211.165(b)21 CFR 211.25(a)21 CFR 211.67(b)21 CFR 211.84(b)

Full citation text and observation details available on the Dashboard.